The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 3 study to determine the breast cancer risk reducing effect of denosumab in women carrying a germline BRCA1 mutation (BRCA-P Study).
 
Nizar Bhulani
No Relationships to Disclose
 
Marie Wood
Consulting or Advisory Role - AstraZeneca (Inst); HERON (Inst)
 
Joy Tsai
Employment - Amgen (I)
Stock and Other Ownership Interests - Amgen (I)
Research Funding - Amgen
 
Isabelle Bedrosian
No Relationships to Disclose
 
Judith O. Hopkins
No Relationships to Disclose
 
Joan Brunet
Consulting or Advisory Role - AstraZeneca Spain; MSD Oncology
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Rachel Michaelson-Cohen
No Relationships to Disclose
 
Rita K. Schmutzler
Honoraria - AstraZeneca; Clovis Oncology; MSD/AstraZeneca
Consulting or Advisory Role - AstraZeneca; MSD/AstraZeneca
Research Funding - Amgen
 
Gareth D Evans
Leadership - AstraZeneca
Consulting or Advisory Role - SpringWorks Therapeutics
 
Michael Gnant
Employment - Sandoz (I)
Honoraria - Amgen; AstraZeneca; Lilly; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Daiichi-Sankyo; LifeBrain; Lilly; Tolmar; Veracyte
 
Christian Fesl
Research Funding - Amgen (Inst); Pfizer (Inst)
 
Aleksandra Mystek
No Relationships to Disclose
 
Geoffrey J Lindeman
Consulting or Advisory Role - Pfizer
Research Funding - Abbvie (Inst); Amgen (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Benefits from The Walter and Eliza Hall Institute of Medical Research; Employee of the Walter and Eliza Hall Institute of Medical Research, which receives milestone and royalty payments related to venetoclax. Employees may be eligible for benefits related to these payments (Inst)
 
Christian F. Singer
Honoraria - AstraZeneca/MedImmune; Daiichi Sankyo Europe GmbH; Novartis
Consulting or Advisory Role - AstraZeneca/MedImmune; Daiichi-Sanyko; Gilead Sciences; Novartis; Sanofi/Aventis
Speakers' Bureau - AstraZeneca/MedImmune; Novartis
Research Funding - AstraZeneca/MedImmune; Myriad Genetics; Novartis; Roche; Sanofi
Travel, Accommodations, Expenses - Novartis; Roche
 
Judy Ellen Garber
Consulting or Advisory Role - Aleta BioTherapeutics (I); GTx (I); H3 Biomedicine (I); Helix BioPharma; Konica Minolta; Kronos Bio (I); Novartis (I)
Research Funding - Ambry Genetics; InVitae; Myriad Genetics; Novartis (I)
Other Relationship - AACR; Adrienne Helis Malvin Medical Research Foundation (I); Breast Cancer Research Foundation; Diana Helis Henry Medical Foundation (I); Facing our Risk of Cancer Empowered; James P. Wilmot Foundation (I)